Valeant offers to buy Zoetis: WSJ

(Reuters) - Canada-based drugmaker Valeant Pharmaceuticals International Inc has approached to buy Zoetis Inc , an animal-health company, the Wall Street Journal reported. Zoetis, spun off from Pfizer Inc in 2013, was valued at $24.85 billion as of Thursday's close, according to Thomson Reuters data. It was not clear what Zoetis's reaction to the approach was, if any, or whether it was open to a sale, the Journal reported, citing people familiar with the matter. (http://on.wsj.com/1fGK